These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 18031860)

  • 1. Synthesis and characterization of poly(2-ethyl 2-oxazoline)-conjugates with proteins and drugs: suitable alternatives to PEG-conjugates?
    Mero A; Pasut G; Dalla Via L; Fijten MW; Schubert US; Hoogenboom R; Veronese FM
    J Control Release; 2008 Jan; 125(2):87-95. PubMed ID: 18031860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEG-Ara-C conjugates for controlled release.
    Schiavon O; Pasut G; Moro S; Orsolini P; Guiotto A; Veronese FM
    Eur J Med Chem; 2004 Feb; 39(2):123-33. PubMed ID: 14987821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological in vitro evaluation of novel PEG-psoralen conjugates.
    Bettio F; Canevari M; Marzano C; Bordin F; Guiotto A; Greco F; Duncan R; Veronese FM
    Biomacromolecules; 2006 Dec; 7(12):3534-41. PubMed ID: 17154485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer-protein and polymer-drug conjugates in cancer therapy.
    Thanou M; Duncan R
    Curr Opin Investig Drugs; 2003 Jun; 4(6):701-9. PubMed ID: 12901229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of uniform protein-polymer conjugates.
    Lele BS; Murata H; Matyjaszewski K; Russell AJ
    Biomacromolecules; 2005; 6(6):3380-7. PubMed ID: 16283769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of degradable functional poly(ethylene glycol) analogs as versatile drug delivery carriers.
    Wang N; Dong A; Tang H; Van Kirk EA; Johnson PA; Murdoch WJ; Radosz M; Shen Y
    Macromol Biosci; 2007 Nov; 7(11):1187-98. PubMed ID: 17665412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of poly(ethylene glycol)-based saquinavir prodrug conjugates and assessment of release and anti-HIV-1 bioactivity using a novel protease inhibition assay.
    Gunaseelan S; Debrah O; Wan L; Leibowitz MJ; Rabson AB; Stein S; Sinko PJ
    Bioconjug Chem; 2004; 15(6):1322-33. PubMed ID: 15546199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyoxazoline: chemistry, properties, and applications in drug delivery.
    Viegas TX; Bentley MD; Harris JM; Fang Z; Yoon K; Dizman B; Weimer R; Mero A; Pasut G; Veronese FM
    Bioconjug Chem; 2011 May; 22(5):976-86. PubMed ID: 21452890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smart PEGylation of trypsin.
    Zarafshani Z; Obata T; Lutz JF
    Biomacromolecules; 2010 Aug; 11(8):2130-5. PubMed ID: 20690720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of polymer molecular weight on the size, activity, and stability of PEG-functionalized trypsin.
    Chiu K; Agoubi LL; Lee I; Limpar MT; Lowe JW; Goh SL
    Biomacromolecules; 2010 Dec; 11(12):3688-92. PubMed ID: 20979350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery.
    Heyes J; Hall K; Tailor V; Lenz R; MacLachlan I
    J Control Release; 2006 May; 112(2):280-90. PubMed ID: 16603272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocator protein (TSPO) ligand-Ara-C (cytarabine) conjugates as a strategy to deliver antineoplastic drugs and to enhance drug clinical potential.
    Denora N; Laquintana V; Trapani A; Lopedota A; Latrofa A; Gallo JM; Trapani G
    Mol Pharm; 2010 Dec; 7(6):2255-69. PubMed ID: 20958082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate coupled poly(ethyleneglycol) conjugates of anionic poly(amidoamine) dendrimer for inflammatory tissue specific drug delivery.
    Chandrasekar D; Sistla R; Ahmad FJ; Khar RK; Diwan PV
    J Biomed Mater Res A; 2007 Jul; 82(1):92-103. PubMed ID: 17269145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long functionalized poly(ethylene glycol)s of defined molecular weight: synthesis and application in solid-phase synthesis of conjugates.
    Niculescu-Duvaz D; Getaz J; Springer CJ
    Bioconjug Chem; 2008 Apr; 19(4):973-81. PubMed ID: 18380471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEG conjugates in clinical development or use as anticancer agents: an overview.
    Pasut G; Veronese FM
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1177-88. PubMed ID: 19671438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibition, drug load, and degradation studies of gelatin/methotrexate conjugates.
    Ofner CM; Pica K; Bowman BJ; Chen CS
    Int J Pharm; 2006 Feb; 308(1-2):90-9. PubMed ID: 16361072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
    Sant S; Poulin S; Hildgen P
    J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEG-metronidazole conjugates: synthesis, in vitro and in vivo properties.
    Bersani C; Berna M; Pasut G; Veronese FM
    Farmaco; 2005 Sep; 60(9):783-8. PubMed ID: 16040031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly (ethylene glycol) prodrug for anthracyclines via N-Mannich base linker: design, synthesis and biological evaluation.
    Zhao YJ; Wei W; Su ZG; Ma GH
    Int J Pharm; 2009 Sep; 379(1):90-9. PubMed ID: 19540322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(2-oxazoline)s: a polymer class with numerous potential applications.
    Hoogenboom R
    Angew Chem Int Ed Engl; 2009; 48(43):7978-94. PubMed ID: 19768817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.